United Therapeutics (UTHR) Misses Q4 EPS by $2.05, Misses on Revenue
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $493.10 -0.31%
Revenue Growth %: -1.2%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: -1.2%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $2.67, $2.05 worse than the analyst estimate of $4.72. Revenue for the quarter came in at $491.5 million versus the consensus estimate of $519.21 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
